CVKD

$6.52-0.45 (-6.46%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Cadrenal Therapeutics, Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPROTranscriptsPROStatementsPRO

Recent News

Zacks
Nov 8, 2025

Cadrenal Therapeutics, Inc.

CVKD: Acquires Factor XIa Inhibitors

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Pharmaceutical Technology
Sep 16, 2025

Cadrenal Therapeutics acquires eXIthera’s Factor XIa inhibitors

Cadrenal will acquire eXIthera’s intravenous Factor XIa inhibitor frunexian, oral inhibitor EP-7327, and additional novel FXIa small molecules.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Apr 6, 2025

Is Cadrenal Therapeutics (NASDAQ:CVKD) In A Good Position To Deliver On Growth Plans?

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.